Cover Image
市場調查報告書

粘液型脂肪瘤:全球臨床實驗趨勢

Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 328416
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
粘液型脂肪瘤:全球臨床實驗趨勢 Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月27日 內容資訊: 英文 80 Pages
簡介

本報告提供全球粘液型脂肪瘤治療藥臨床實驗相關調查,提供您各地區的臨床試驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷 (暫時停止、廢止、停止) 的實驗清單等資訊。

簡介

  • 粘液型脂肪瘤
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上粘液型脂肪瘤的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:治療藥臨床實驗上粘液型脂肪瘤的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

粘液型脂肪瘤治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Eisai
    • CTI BioPharma Corp.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Fred Hutchinson Cancer Research Center
    • Leiden University Medical Center
    • Vector Oncology
    • The Alliance for Clinical Trials in Oncology
    • Fondazione IRCCS - Istituto Nazionale dei Tumori
    • Grupo Espanol de Investigacion en Sarcomas
    • Istituto Nazionale per lo Studio e la Cura dei Tumori
    • European Organization for Research and Treatment of Cancer

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2588CTIDB

GlobalData's clinical trial report, "Myxoid Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Myxoid Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myxoid Liposarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myxoid Liposarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myxoid Liposarcoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Myxoid Liposarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myxoid Liposarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myxoid Liposarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • CTI BioPharma Corp.
      • Clinical Trial Overview of CTI BioPharma Corp.
    • Clinical Trial Overview of Top Institutes / Government
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Vector Oncology
      • Clinical Trial Overview of Vector Oncology
      • The Alliance for Clinical Trials in Oncology
      • Clinical Trial Overview of The Alliance for Clinical Trials in Oncology
      • Fondazione IRCCS - Istituto Nazionale dei Tumori
      • Clinical Trial Overview of Fondazione IRCCS - Istituto Nazionale dei Tumori
      • Grupo Espanol de Investigacion en Sarcomas
      • Clinical Trial Overview of Grupo Espanol de Investigacion en Sarcomas
      • Istituto Nazionale per lo Studio e la Cura dei Tumori
      • Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Myxoid Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by CTI BioPharma Corp., 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vector Oncology, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Alliance for Clinical Trials in Oncology, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione IRCCS - Istituto Nazionale dei Tumori, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grupo Espanol de Investigacion en Sarcomas, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*

List of Figures

  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Myxoid Liposarcoma to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Myxoid Liposarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Myxoid Liposarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Myxoid Liposarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top